Skip to main content

Table 1 Demographic and Clinical Characteristics of subjects

From: The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis

Parameter 
Age (year) [Mean (SD)]35.45 (8.08)
Disease Duration [Mean (SD)]7.63 (5.56)
Age of onset of disease [Mean (SD)]26.85(7.81)
Sex [n (%)]
 Female474 (78.7)
 Male128 (21.3)
Marital status [n (%)]
 Single149 (24.8)
 Married415 (68.9)
 Divorced and widowed38 (6.3)
Education level [n (%)]
 Secondary school or below145 (24)
 high school214 (35.5)
 University244 (40.5)
Job status [n (%)]
 Employed128 (21.2)
 Unemployed52 (8.6)
 housewife378 (62.7)
 Retired and disabled45 (7.5)
Current comorbid conditions [n (%)]
 Diabetes7 (1.2)
 Arthritis8 (1.3)
 Hypertension17 (2.8)
 Heart disease5 (0.8)
 Thyroid disorders40 (6.6)
 Migraine37 (6.1)
 Asthma8 (1.3)
 Inflammatory bowel disease9 (1.5)
 kidney disease14 (2.3)
 Liver disease4 (0.7)
 infectious disorders2 (0.3)
 Skin disorders2 (0.3)
 Epilepsy11 (1.8)
 Other disorders64 (10.6)
 None375 (62.1)
EDSS Score [Mean (SD)]2.45 (2.11)
EDSS Class [n (%)]
 Mild (1–3)432 (71.6)
 Moderate (3.5–6.5)151 (25)
 Severe (≥ 7)20 (3.4)
Course disease [n (%)]
 Relapsing remitting459 (76.1)
 Primary progressive19 (3.2)
 Secondary progressive97 (16.1)
 CIS28 (4.6)
MS medication [n (%)]
 Interferon beta203 (33.7)
 Glatiramer acetate47 (7.8)
 Fingolimod114 (18.9)
 Natalizumab injection41 (6.8)
 Azathioprine20 (3.3)
 Ritoximab injection97 (16.1)
 Mitoxantrone1 (0.2)
 Dimethilfumarat13 (2.2)
 Trifulonumaide4 (0.7)
 Mix (Azathioprine&Interferonbeta)24 (4)
 Cyclophosmaide8 (1.3)
 Metotruxat3 (0.5)
 None28 (4.6)
Symptomatic treatment [n (%)]
 Anti-depressant119(19.8)
 Anticonvulsants111(18.4)
 Anti-anxiety40(6.6)
 Antipsychotic17(2.8)
 Anticholinergic103(17.1)
 anti-spasticity86(14.3)
 Anti-fatigue56(9.3)
 Beta blocker37(6.1)
 Levothyroxine26(4.3)
 anti-Anemia35(5.8)
 Amantadine15(2.5)
 supplements377(62.6)
 Anti-lipid8(1.3)
 NSAID10(1.7)
 Alpha Adrenergic Inhibitor16(2.7)
 Anti-acid39(6.5)
 Modafinil8(1.3)
  1. SD: Standard deviation; EDSS: Expanded Disability Status Scale